LODH Immunology Fund
VC Fund
Geneva, Switzerland
LODH Immunology Fund is a VC fund in Geneva focused on Medical and Health Care. The LODH Immunology Fund is a Swiss open-ended mutual fund managed by Lombard Odier Darier Hentsch & Cie, a Swiss private bank. Approximately 20% of the assets of the fund are invested in privately held biotech companies.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries LODH Immunology Fund invests in
Stages LODH Immunology Fund invests in
Countries LODH Immunology Fund invests in
Investment Focus
Industry
- Medical 1 (100%)
- Health Care 1 (100%)
- Biotechnology 1 (100%)
- Manufacturing 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Genmab
|
Genmab is an international biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer. Genmab's discovery, development, and manufacturing teams are using cutting-edge technology to create and develop products to address unmet medical needs. Its primary goal is to improve the lives ofpatients who are in urgent need of new treatment options. | $40.5M / Jun 13, 2000 |
Co-Investors
Apax Partners France
1 deal together
BankInvest Biomedical Venture
1 deal together
Dansk Erhvervsinvestering
1 deal together
Index Ventures
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does LODH Immunology Fund invest in?
LODH Immunology Fund invests primarily in Medical, Health Care and Biotechnology startups, most often at Funding Round stage. Most of the 1 investments tracked by Shizune back companies in Denmark. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did LODH Immunology Fund last invest?
The most recent investment recorded for LODH Immunology Fund closed in Jun 2000. Shizune tracks 1 investment in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
